A detailed history of Engineers Gate Manager LP transactions in Repligen Corp stock. As of the latest transaction made, Engineers Gate Manager LP holds 10,446 shares of RGEN stock, worth $1.48 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,446
Previous 12,406 15.8%
Holding current value
$1.48 Million
Previous $1.56 Million 0.58%
% of portfolio
0.03%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.79 - $167.35 $234,788 - $328,006
-1,960 Reduced 15.8%
10,446 $1.55 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $1.15 Million - $1.75 Million
9,575 Added 338.22%
12,406 $1.56 Million
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $483,478 - $590,037
2,831 New
2,831 $520,000
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $117,103 - $152,542
-846 Reduced 30.15%
1,960 $277,000
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $432,853 - $555,868
2,806 New
2,806 $472,000
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $1.79 Million - $2.86 Million
11,150 New
11,150 $2.09 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $210,203 - $258,495
-849 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $165,359 - $275,254
849 New
849 $245,000
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $204,849 - $272,873
-1,235 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $222,756 - $279,431
1,235 New
1,235 $240,000
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $2 Million - $2.79 Million
-13,523 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $1.66 Million - $2.14 Million
13,523 New
13,523 $2 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.87B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.